Clinical Trial Update: Expanded Access of Omegaven IV Fat Emulsion to Infants and Children With PNALD

View source ↗

Summary

Marketing approval has been granted for Omegaven IV fat emulsion to treat total parenteral nutrition-induced cholestasis in infants and children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Parenteral Nutrition-induced Cholestasis

Drugs mentioned

• Omegaven (fish oil-based intravenous fat emulsion)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Total Parenteral Nutrition-induced Cholestasis | Status: APPROVED_FOR_MARKETING